Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Huge Patient Pool with Sedentary Lifestyle and Rapidly Growing Aging Population
4.2.2 Rise in Awareness About Vitamin D Deficiency by the Government and Manufacturers
4.3 Market Restraints
4.3.1 Fortification of Foods
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 Route of Administration
5.1.1 Oral
5.1.2 Parenteral
5.2 Purchasing Patterns
5.2.1 Prescription
5.2.2 Over-The-Counter
5.3 Application
5.3.1 Osteoporosis
5.3.2 Muscle Weakness
5.3.3 Autoimmune Disorders
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ortho Molecular Products Inc
6.1.2 Biotics Research Corporation
6.1.3 GlaxoSmithKline PLC
6.1.4 Abbott Laboratories
6.1.5 Pfizer Inc
6.1.6 Novartis AG
6.1.7 Merck & Co Inc
6.1.8 Cadila Healthcare Ltd
6.1.9 Alkem Laboratories Ltd
6.1.10 Torrent Pharmaceuticals Ltd


7 MARKET OPPORTUNITIES AND FUTURE TRENDS